Transition Intermediates Encode Ligand Efficacy at the μ-Opioid Receptor-Gi Protein Complex
Kirill A. KonovaloviD, Dylan NovackiD, Davide ProvasiiD, Vishal MaingiiD, Georgios SkiniotisiD, Marta FilizolaiD
Abstract
How ligands with different efficacies regulate G protein-coupled receptor signaling remains incompletely understood. Here, we combine Markov state modeling of nearly one millisecond of aggregate all-atom molecular dynamics simulations with time-resolved cryogenic-electron microscopy (cryo-EM) to reconstruct the most probable transition pathways connecting recently resolved structures of guanosine triphosphate (GTP)-bound -opioid receptor (MOR)-Gi1 complexes with the full agonist lofentanil (LFT) or partial agonist mitragynine pseudoindoxyl (MP). The models predict four previously unresolved intermediate conformations. Guided by these predictions, reanalysis of the cryo-EM particle ensemble identifies conformational populations consistent with all four intermediates. Remarkably, the largest ligand-dependent structural differences emerge within these intermediates rather than in the previously resolved states. LFT favors a predominantly sequential and kinetically efficient transition pathway, whereas MP stabilizes a broader intermediate ensemble along this pathway and slows progression toward later states. Together, these complementary approaches provide an enriched thermodynamic and kinetic description of MOR-mediated G protein activation, revealing that opioid efficacy is encoded, at least in part, in the differential stabilization and kinetics of transition intermediates extending beyond GTP binding but well before complete G protein dissociation.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Non-Equilibrium Snapshots of Ligand Efficacy at the μ-Opioid Receptor
Michael J. Robertson, Arnab Modak, … Georgios Skiniotis·NaturePeer-reviewed·Dec 22, 2025
- Structural insights into distinct signaling profiles of the μOR activated by diverse agonists
Q. Qu, W. Huang, … G. Skiniotis·bioRxiv·Dec 7, 2021
- Ligand-dependent G protein dynamics underlying opioid signaling efficacy
Jonathan C. Deutsch, Daniel Hilger, … Rabindra V. Shivnaraine·bioRxiv·Jun 30, 2025
- Buprenorphine Restricts the Conformational Landscape of the μ-Opioid Receptor
Simone Aureli, Maria Bzówka, … Francesco Luigi Gervasio·bioRxiv·Jun 16, 2026
- Conformational dynamics of the μ-opioid receptor determine ligand intrinsic efficacy
- Intracellular pocket conformations determine signaling through the μ opioid receptor
David A. Cooper, Joseph DePaolo-Boisvert, … David D. L. Minh·Journal of Chemical Information and ModelingPeer-reviewed·Jan 17, 2025